StreetInsider.com News Articles

StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 20 May 2026 06:55:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Avricore Health Announces $1.25 Million Financing http://www.streetinsider.com/Press+Releases/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.</p> <p align="justify">Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the http://www.streetinsider.com/Press+Releases/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html Wed, 20 May 2026 06:55:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 Avricore Health Announces $1.25 Million Financing http://www.streetinsider.com/Press+Releases/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.</p> <p align="justify">Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the http://www.streetinsider.com/Press+Releases/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html Wed, 20 May 2026 06:55:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 Avricore Health Announces $1.25 Million Financing http://www.streetinsider.com/Press+Releases/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.</p> <p align="justify">Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the http://www.streetinsider.com/Press+Releases/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html Wed, 20 May 2026 06:55:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 Avricore Health Announces $1.25 Million Financing http://www.streetinsider.com/Press+Releases/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.</p> <p align="justify">Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the http://www.streetinsider.com/Press+Releases/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html Wed, 20 May 2026 06:55:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 Avricore Health Announces $1.25 Million Financing http://www.streetinsider.com/Press+Releases/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.</p> <p align="justify">Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the http://www.streetinsider.com/Press+Releases/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html Wed, 20 May 2026 06:55:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 Avricore Health Announces $1.25 Million Financing http://www.streetinsider.com/Globe+Newswire/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.</p> <p align="justify">Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the http://www.streetinsider.com/Globe+Newswire/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html Wed, 20 May 2026 06:55:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 Avricore Health Announces $1.25 Million Financing http://www.streetinsider.com/Globe+Newswire/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.</p> <p align="justify">Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the http://www.streetinsider.com/Globe+Newswire/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html Wed, 20 May 2026 06:55:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 Avricore Health Announces $1.25 Million Financing http://www.streetinsider.com/Globe+Newswire/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.</p> <p align="justify">Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the http://www.streetinsider.com/Globe+Newswire/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html Wed, 20 May 2026 06:55:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 Avricore Health Announces $1.25 Million Financing http://www.streetinsider.com/Globe+Newswire/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.</p> <p align="justify">Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the http://www.streetinsider.com/Globe+Newswire/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html Wed, 20 May 2026 06:55:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 Avricore Health Announces $1.25 Million Financing http://www.streetinsider.com/Globe+Newswire/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.</p> <p align="justify">Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the http://www.streetinsider.com/Globe+Newswire/Avricore+Health+Announces+%241.25+Million+Financing/26524545.html Wed, 20 May 2026 06:55:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 Form 6-K Avricore Health Inc. For: Apr 30 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Apr+30/26464217.html si-local-file:///var/storage/secattach/20260511/26464217.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Apr+30/26464217.html Mon, 11 May 2026 06:02:00 -0400 AVCR AVCRF O.71644544 Form 6-K Avricore Health Inc. For: Apr 30 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Apr+30/26464217.html si-local-file:///var/storage/secattach/20260511/26464217.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Apr+30/26464217.html Mon, 11 May 2026 06:02:00 -0400 AVCR AVCRF O.71644544 Form 6-K Avricore Health Inc. For: Apr 30 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Apr+30/26464217.html si-local-file:///var/storage/secattach/20260511/26464217.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Apr+30/26464217.html Mon, 11 May 2026 06:02:00 -0400 AVCR AVCRF O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html <p>VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the "<strong>Company</strong>" or “<strong>Avricore</strong>”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada.</p> <p><strong>Expansion Roadmap</strong></p> <p>The Company has published “<strong>The Path Forward</strong>,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation http://www.streetinsider.com/Press+Releases/Avricore+Health+Achieves+Milestones+and+Outlines+UK+Expansion+Roadmap+for+HealthTab%E2%84%A2+Platform/26339481.html Tue, 21 Apr 2026 06:30:00 -0400 A.03186153 A.14320728 A.24048431 A.36078215 A.36354767 A.50215242 AVCR AVCRF O.00396385 O.02555813 O.13550856 O.20250741 O.22561336 O.50921235 O.71644544